An Understanding

At Memorial Sloan Kettering Cancer Center, biopsies from patients now head to a new lab where they are examined to determine whether they house any of 341 genetic mutations, Bloomberg reports. Knowing whether the tumor harbors any of these changes can help guide the patient's treatment, it adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.